Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • ShortsalgSe hvilke børsnoterede selskaber der har offentliggjorte korte positioner
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Borregaard ASA: EBITDA1 of NOK 428 million in the 1st quarter

BRGSelskabsmeddelelse29.04.2026, 07.00

Borregaard’s operating revenues were NOK 2,005 million (NOK 2,036 million) in the 1st quarter of 2026. EBITDA1 was NOK 428 million (NOK 511 million). The result in Fine Chemicals increased, while BioSolutions and BioMaterials had lower results compared with the 1st quarter of 2025.

Within BioSolutions' specialities, lower sales volume was partly compensated by higher sales prices. The lower sales volume was due to a temporary delay in the value chain, driven by geopolitical factors, broader uncertainty, and customer destocking. For BioMaterials, higher deliveries of speciality cellulose were offset by lower sales prices and a weaker product mix. In Fine Chemicals, higher deliveries and a favourable product mix within fine chemical intermediates were the main reasons for the improved result. Net currency effects were insignificant for the Group.

Profit before tax was NOK 230 million (NOK 319 million). Earnings per share were NOK 1.82 (NOK 2.52).

“While BioSolutions was impacted by a temporary delay in the value chain, demand for speciality cellulose increased and Fine Chemicals delivered a strong performance. Overall results were affected by continued cost pressure, partly driven by geopolitical developments. We are implementing targeted measures to address the cost”, says CEO Tom Erik Foss-Jacobsen.

Contacts:
Director Investor Relations, Pål Espen Ramberg, +47 959 17 333
Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and expenses
2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on 29 April 2026 at 07:00 CEST.

Attachments

  • 1st quarter 2026 presentation
  • 1st quarter 2026 report
  • Quarterly and accounting figures 1st quarter 2026